Executive Director and Chief Executive Officer Yang Jian increased his shareholding in CStone Pharmaceuticals-B (02616.HK) by 132,500 shares at approximately HK$5.24 per share.

Zhito Finance APP has learned that the latest data from the Hong Kong Stock Exchange shows that on September 17, Yang Jianxin, Executive Director and Chief Executive Officer, increased his holdings of CStone Pharmaceuticals-B (02616.HK) by 132,500 shares at HK$5.2361 per share, for a total amount of approximately HK$693,800. After the increase, his latest shareholding stood at approximately 84,416,600 shares, with the latest shareholding ratio at 5.29%.